Apogee Therapeutics Inc

Apogee Therapeutics insider trades reveal CMO confidence in Phase 2 milestones, fast‑track ADC pipeline, and value‑based commercialization strategy.

Apogee Therapeutics CFO insider sales reveal disciplined liquidity management, not looming distress, and highlight the firm’s biotech strategy, R&D focus, and market positioning in value‑based care.